Point of Care (POC) HIV Testing Market Projected to Reach USD 2,500 million, with a Robust 7.4% CAGR Till 2035

WiseGuy Reports, Oct. 2025 (Press Release) – The Point of Care (POC) HIV Testing Market Global Outlook:

Global Point of Care (POC) HIV Testing Market Growth Analysis and Trends Report Test Type (Antibody Tests, Antigen Tests, Viral Load Tests, Combination Tests), By End User (Hospitals, Clinics, Home Care Settings, Public Health Organizations), By Distribution Channel (Direct Sales, Distributors, Online Sales), By Sample Type (Blood Samples, Oral Fluid Samples, Urine Samples) and By Regions - Global Industry Forecast 2025 to 2035

Point of Care (POC) HIV Testing Market Overview

The global Point of Care (POC) HIV Testing Market is evolving rapidly as healthcare systems prioritize accessibility, speed, and early detection. With the increasing prevalence of HIV and the need for rapid, on-site diagnosis, POC testing has emerged as a cornerstone of modern public health strategy. According to recent data, the Point of Care (POC) HIV Testing Market size reached USD 1,143.2 million in 2024, projected to grow to USD 1,227.8 million in 2025, and further expand to USD 2,500 million by 2035, reflecting a CAGR of 7.4% during 2025–2035.

Market Overview

The Point of Care (POC) HIV Testing Market is witnessing strong growth driven by technological innovation and global initiatives to combat HIV/AIDS. These tests enable rapid detection of HIV antibodies or antigens at or near the site of patient care, bypassing the need for centralized laboratory infrastructure. This not only accelerates diagnosis but also facilitates timely treatment initiation and disease management.

The demand for POC HIV testing is growing across hospitals, clinics, community centers, and mobile health units. Increased focus on decentralized diagnostics, government-backed screening programs, and public health awareness campaigns is propelling adoption globally.

Request To Free Sample of This Strategic Report: https://www.wiseguyreports.com/sample-request?id=735985

Key Market Dynamics

Several crucial factors are shaping the Point of Care (POC) HIV Testing Market landscape:

• Rising prevalence of HIV: According to WHO and UNAIDS, millions of individuals live with HIV globally, underscoring the urgency for early, accessible, and reliable testing solutions.
• Rapid test technology advancements: Development of next-generation immunoassays and molecular diagnostic platforms is enhancing test accuracy and reducing turnaround time.
• Growing demand for decentralized testing: Remote and rural healthcare facilities increasingly depend on POC testing to reach populations with limited laboratory access.
• Enhanced healthcare accessibility: Expansion of community-based screening programs and mobile testing units has improved reach, particularly in low- and middle-income regions.
• Government funding initiatives: National HIV control programs and global funding mechanisms, such as PEPFAR and the Global Fund, are driving large-scale adoption of POC testing devices.

However, challenges such as supply chain constraints, limited trained personnel, and variability in test sensitivity in early infection stages remain key barriers to full-scale deployment.

Market Segmentation

The Point of Care (POC) HIV Testing Market is segmented by test type, sample type, end user, distribution channel, and region.

• By Test Type: Includes antibody tests, antigen/antibody combination tests, and nucleic acid tests. Antibody-based rapid tests dominate the market due to ease of use and low cost, while nucleic acid tests are gaining traction for their ability to detect early infections.
• By Sample Type: Blood, oral fluid, and plasma samples are commonly used. Oral fluid tests are increasingly popular for non-invasive, community-based testing initiatives.
• By End User: Hospitals, diagnostic laboratories, NGOs, and community health centers represent key end users. Community health centers and outreach programs are major growth drivers.
• By Distribution Channel: Includes direct sales, distributors, and online platforms, with distributors playing a crucial role in ensuring product availability across emerging markets.

Regional Insights

North America holds a leading position in the Point of Care (POC) HIV Testing Market, supported by advanced healthcare infrastructure, proactive screening programs, and the presence of major diagnostic players such as Abbott Laboratories, BD, and OraSure Technologies. The U.S. remains the largest market in the region, backed by government-led HIV prevention campaigns and public health funding.

Europe follows closely, with strong demand in Germany, the U.K., and France due to established HIV testing frameworks and emphasis on early detection. The region’s focus on self-testing kits and home-based diagnostics further supports market expansion.

The Asia-Pacific (APAC) region is expected to witness the fastest growth through 2035. Countries such as India, China, and Thailand are implementing widespread HIV awareness campaigns and integrating POC testing into national health initiatives. Expanding healthcare access in rural communities and government support for mass testing programs are major growth accelerators.

South America and the Middle East & Africa (MEA) also present high growth potential, particularly in Brazil, South Africa, and GCC countries, where HIV prevalence remains significant and healthcare accessibility is improving.

You Can Purchase Complete Report: https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=735985

Competitive Landscape

The Point of Care (POC) HIV Testing Market is characterized by strong competition among diagnostic technology leaders focusing on innovation and affordability. Key companies include:

• Bio-Rad Laboratories
• Quidel Corporation
• Hologic Inc.
• Thermo Fisher Scientific
• Cepheid (Danaher Corporation)
• BD (Becton, Dickinson and Company)
• Abbott Laboratories
• OraSure Technologies
• Alere Inc.
• Roche Diagnostics
• Chembio Diagnostics
• Siemens Healthineers

These players are investing in product innovation, regulatory approvals, and collaborations with public health organizations. Many are developing next-generation rapid test kits that integrate digital connectivity, enabling results to be transmitted to healthcare databases and mobile health platforms in real time.

Growth Opportunities

The Point of Care (POC) HIV Testing Market offers multiple growth avenues over the next decade:

• Integration with mobile health platforms: Combining POC devices with digital reporting and telemedicine will enhance surveillance and patient engagement.
• Expanding rural access: Increasing distribution in underserved regions will significantly boost market penetration.
• Government funding and partnerships: Strategic collaborations between diagnostic companies and public health bodies will expand screening programs.
• Technological innovation: Miniaturized, multiplexed, and AI-enhanced POC systems are emerging as the next frontier.
• Awareness and education: Ongoing campaigns promoting voluntary testing and destigmatization will drive broader acceptance.

Future Outlook

The Point of Care (POC) HIV Testing Market is set for steady expansion as global healthcare systems continue to emphasize early detection, real-time diagnostics, and equitable access. By 2035, with a projected market value of USD 2.5 billion, POC testing will play an even more vital role in HIV management and prevention strategies.

Driven by technological innovation, public health investment, and digital integration, the Point of Care (POC) HIV Testing Market will remain a key enabler of global health equity—bridging gaps in diagnosis and empowering healthcare providers to act faster and more effectively in the fight against HIV/AIDS.

Browse In-depth Market Research Report (Pages, Charts, Tables, Figures): https://www.wiseguyreports.com/reports/point-of-care-poc-hiv-testing-market

Reasons To Buy The Point of Care (POC) HIV Testing Market Report:

➼ In-depth analysis of the Point of Care (POC) HIV Testing Market on the global and regional levels.

➼ Major changes in market dynamics and competitive landscape.

➼ Segmentation on the basis of type, application, geography, and others.

➼ Historical and future market research in terms of size, share growth, volume, and sales.

➼ Major changes and assessment in market dynamics and developments.

➼ Emerging key segments and regions

➼ Key business strategies by major market players and their key methods

Other Related Reports from Latest WiseGuy Reports:

CoolSculpting and ZELTIQ Market

Consumption Type Vaccine Market

Curved Nasal Cannula Market

Cosmetic Surgery Procedure Market

Clinical Trial Planning Design Services Market

Children's Eye Care Products Market

Co-Immunoprecipitation Kits Market

Cefpodoxime Proxetil Tablets Market

Colored Microsphere Market

Chemotherapy for Neuroblastoma Market

About US:

Wise Guy Reports is pleased to introduce itself as a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. We want our clients to have information that can be used to act upon their strategic initiatives. We, therefore, aim to be your trustworthy partner within dynamic business settings through excellence and innovation. By offering comprehensive market intelligence, our company enables corporate organizations to make informed choices, drive growth, and stay ahead in competitive markets